First Ovarian Cancer Patient Dosed in Phase 1 Trial of Solid-Tumor Therapy Celyad
News
The U.S. arm of a Phase 1 clinical trial of Celyad as a solid-tumor treatment has kicked off with the dosing of the first ovarian cancer patient at the Roswell Park Cancer Institute in ... Read more